In line with these studies described above, this study found that HCP5 knockdown inhibited the migration and proliferation of U251 and primary glioblastoma cells and prevented tumor growth in xenograft mice, which suggested that HCP5 exerted a tumor-promotor role in gliomas. This evidence concerns the gene HCP5 and central nervous system cancer.